Financial Daily from THE HINDU group of publications
Friday, Sep 16, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Alliances & Joint Ventures


Gangagen Life Sciences ties up with Elanco

Our Bureau

Bangalore , Sept. 15

GANGAGEN Life Sciences Inc has signed an agreement with Elanco Animal Health, an Eli Lilly division, for collaborative research, licencing and commercialisation of anti-bacterial products derived from bacteriophages.

The company's President and CEO, Dr J. Ramachandran, did not disclose the financial terms. Elanco, with operations in 100 countries, develops and markets animal health products.

Gangagen is banking on developing its technologies into anti-bacterial products in a couple of years for cattle, poultry, and humans for hospital- and urinary tract infections.

It expects revenues of $50 million by 2009-10 from these products, Dr Ramachandran said.

The company has demonstrated the benefits of its first phage product for the control of E.coli 0157 in cattle and expects to complete large-scale field trials and get regulatory approval for the product.

It has so far invested up to $5 million in its research and will be putting in another $6-8 million soon. It has received a $2-million funding from ICF Ventures. Gangagen recently received two broad US patents for its bacteriophage technologies.

The tie-up will build on Gangagen's phage technology expertise and Elanco's commercial experience, Dr Ramachandran said. Eli Lilly was an early innovator of phage technology in the 1930s before the introduction of antibiotics.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Banknet India Tata Safari Dicor

Stories in this Section
MRPL to raise capacity to 15 million tonne


Honda contends with heavy order backlog for Activa
Kothari Sugars settles dues through restructure package
MRPL approves 10 pc dividend
Hatsun Agro to close Kolkata unit
INOX Leisure to foray into film distribution — Plans Rs 100-cr expansion
GVSL sells stake in Lokesh Machines
Tantea bags `largest tea seller' award
GE Shipping board approves demerger of offshore services
Sun Pharma buys Valeant's Ohio facility
Gangagen Life Sciences ties up with Elanco
BHEL's Tiruchi unit to look for ancillaries in North
Joint venture partner for SPIC Petro soon
Tata Tea in talks with US cos for biz prospects
Eppendorf India keen on tapping biotech market
SRMB 500 bars launched in Vizag
Appointment of independent directors according to norms: Aiyar


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line